0000899243-20-031942.txt : 20201123
0000899243-20-031942.hdr.sgml : 20201123
20201123173053
ACCESSION NUMBER: 0000899243-20-031942
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201119
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SELLERS LISA
CENTRAL INDEX KEY: 0001829669
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39725
FILM NUMBER: 201339133
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARAVAI LIFESCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001823239
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 546-0004
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-19
0
0001823239
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI
0001829669
SELLERS LISA
C/O MARAVAI LIFESCIENCES HOLDINGS, INC.
10770 WATERIDGE CIRCLE, SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
See Remarks
Employee Stock Options (Right to Buy)
27.00
2020-11-19
4
A
0
60000
0.00
A
2030-11-19
Class A Common Stock
60000
60000
D
Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer.
Chief Operating Officer, Protein Detection
/s/ Kurt Oreshack, by power of attorney for Lisa Sellers
2020-11-23